{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:40:03Z","timestamp":1790343603542,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.gene.2018.12.046","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T17:43:35Z","timestamp":1547055815000},"page":"145-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Halcyon days of TOR: Reflections on the multiple independent discovery of the yeast and mammalian TOR proteins"],"prefix":"10.1016","volume":"692","author":[{"given":"George P.","family":"Livi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2018.12.046_bb0005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1101\/gad.10.3.279","article-title":"Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast","volume":"10","author":"Alarcon","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.gene.2018.12.046_bb0010","first-page":"204","article-title":"Condensation and summary: rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein","volume":"2","author":"Albers","year":"1991","journal-title":"ChemTracts \u2013 Biochem. Mol. Biol."},{"key":"10.1016\/j.gene.2018.12.046_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1091\/mbc.7.1.25","article-title":"TOR controls translation initiation and early G1 progression in yeast","volume":"7","author":"Barbet","year":"1996","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0020","first-page":"868","article-title":"Rapamycin passes the torch: a new generation of mTOR inhibitors","volume":"10","author":"Benjamin","year":"2011","journal-title":"Nat. Rev."},{"key":"10.1016\/j.gene.2018.12.046_bb0025","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1091\/mbc.e08-10-1001","article-title":"TORC2 plasma membrane localization is essential for cell viability and restricted to a distinct domain","volume":"20","author":"Berchtold","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0030","doi-asserted-by":"crossref","first-page":"23204","DOI":"10.1016\/S0021-9258(18)54484-7","article-title":"The cyclophilin multigene family of peptidyl-prolyl isomerases: characterization of three separate human isoforms","volume":"266","author":"Bergsma","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2018.12.046_bb0035","doi-asserted-by":"crossref","first-page":"9231","DOI":"10.1073\/pnas.87.23.9231","article-title":"Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin","volume":"87","author":"Bierer","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2018.12.046_bb0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cell.2017.08.019","article-title":"TOR, the gateway to cellular metabolism, cell growth, and disease","volume":"171","author":"Blenis","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/bj2970365","article-title":"Catalytic and ligand binding properties of the FK506 binding protein FKBP12: effects of the single amino acid substitution of Tyr82 to Leu","volume":"297","author":"Bossard","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.gene.2018.12.046_bb0050","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.7164\/antibiotics.48.1347","article-title":"27-O-demethylrapamycin, an immunosuppressant compound produced by a new strain of Streptomyces hygroscopicus","volume":"48","author":"Box","year":"1995","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.gene.2018.12.046_bb0055","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1128\/MCB.11.9.4616","article-title":"Antifungal properties of the immunosuppressant FK-506: identification of an FK-506 responsive yeast gene distinct from FKB1","volume":"11","author":"Brizuela","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.gene.2018.12.046_bb0060","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by G1-arresting rapamycin-receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.gene.2018.12.046_bb0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/377441a0","article-title":"Control of p70 s6 kinase by kinase activity of FRAP in vivo","volume":"377","author":"Brown","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.gene.2018.12.046_bb0070","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1128\/MCB.13.10.6012","article-title":"Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity","volume":"13","author":"Cafferkey","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.gene.2018.12.046_bb0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0378-1119(94)90141-4","article-title":"Yeast TOR (DRR) proteins: amino acid sequence alignment and identification of structural motifs","volume":"141","author":"Cafferkey","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.gene.2018.12.046_bb0080","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.1073\/pnas.89.16.7571","article-title":"Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin","volume":"89","author":"Calvo","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2018.12.046_bb0085","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1073\/pnas.92.11.4947","article-title":"Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue","volume":"92","author":"Chen","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2018.12.046_bb0090","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.1073\/pnas.91.26.12574","article-title":"RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12\/rapamycin complex","volume":"91","author":"Chiu","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2018.12.046_bb0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.273.5272.239","article-title":"Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP","volume":"273","author":"Choi","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.gene.2018.12.046_bb0100","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0092-8674(92)90643-Q","article-title":"Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70\u202fkd S6 protein kinases","volume":"69","author":"Chung","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0105","first-page":"903","article-title":"Rapamycin selectively inhibits growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor","volume":"54","author":"Dilling","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2018.12.046_bb0110","doi-asserted-by":"crossref","first-page":"12907","DOI":"10.1073\/pnas.91.26.12907","article-title":"The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-\u03b2-d-glucan synthase","volume":"91","author":"Douglas","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2018.12.046_bb0115","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.4049\/jimmunol.144.4.1418","article-title":"The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells","volume":"144","author":"Dumont","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.gene.2018.12.046_bb0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4049\/jimmunol.144.1.251","article-title":"Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin","volume":"144","author":"Dumont","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.gene.2018.12.046_bb0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-1119(94)90633-5","article-title":"The yeast FKS1 gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth","volume":"151","author":"Eng","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.gene.2018.12.046_bb0130","series-title":"Francis Bacon: Philosopher of Industrial Science","author":"Farrington","year":"1949"},{"key":"10.1016\/j.gene.2018.12.046_bb0135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/360682a0","article-title":"Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from alpha-factor arrest in yeast","volume":"360","author":"Foor","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.gene.2018.12.046_bb0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0378-1119(96)00168-0","article-title":"Missense mutations at the FKBP12-rapamycin binding site of TOR1","volume":"172","author":"Freeman","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.gene.2018.12.046_bb0145","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1158\/1078-0432.CCR-08-3007","article-title":"Concurrent and sequential administration of chemotherapy and the mammalian target of rapamycin inhibitor temsirolimus in human cancer cells and xenografts","volume":"15","author":"Fung","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2018.12.046_bb0150","series-title":"Current Contents","first-page":"660","article-title":"Multiple independent discovery and creativity in science","volume":"vol. 44","author":"Garfield","year":"1980"},{"key":"10.1016\/j.gene.2018.12.046_bb0155","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.tibs.2016.04.001","article-title":"TORC2 structure and function","volume":"41","author":"Gaubitz","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.gene.2018.12.046_bb0160","series-title":"In the Air. Who Says Big Ideas Are Rare?","author":"Gladwell","year":"2008"},{"key":"10.1016\/j.gene.2018.12.046_bb0165","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1158\/2159-8290.CD-13-0929","article-title":"A diverse array of cancer-associated mTOR mutations are hyperactivating and can predict rapamycin sensitivity","volume":"4","author":"Grabiner","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.gene.2018.12.046_bb0170","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0092-8674(95)90439-5","article-title":"X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex","volume":"82","author":"Griffith","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0175","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.267pe24","article-title":"The pharmacology of mTOR inhibition","author":"Guertin","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.gene.2018.12.046_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41557-018-0187-4","article-title":"Rapamycin-inspired macrocycles with new target specificity","author":"Guo","year":"2018","journal-title":"Nat. Chem."},{"key":"10.1016\/j.gene.2018.12.046_bb0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0378-1119(89)90401-0","article-title":"Yeast cyclophilin: isolation and characterization of the protein, cDNA and gene","volume":"83","author":"Haendler","year":"1989","journal-title":"Gene"},{"key":"10.1016\/j.gene.2018.12.046_bb0190","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.6238408","article-title":"Cyclophilin: a specific cytosolic binding protein for cyclosporine A","volume":"226","author":"Handschumacher","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.gene.2018.12.046_bb0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0200","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/341758a0","article-title":"A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase","volume":"341","author":"Harding","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.gene.2018.12.046_bb0205","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1126\/science.1715094","article-title":"Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast","volume":"253","author":"Heitman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.gene.2018.12.046_bb0210","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1073\/pnas.88.5.1948","article-title":"FK506-binding protein proline rotamase is a target for the immunosuppressive agent FK506 in Saccharomyces cerevisiae","volume":"88","author":"Heitman","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2018.12.046_bb0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1091\/mbc.5.1.105","article-title":"TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast","volume":"5","author":"Helliwell","year":"1994","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/genetics\/148.1.99","article-title":"TOR2 is part of two related signaling pathways coordinating cell growth in Saccharomyces cerevisiae","volume":"148","author":"Helliwell","year":"1998","journal-title":"Genetics"},{"key":"10.1016\/j.gene.2018.12.046_bb0225","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0960-894X(01)80998-7","article-title":"Structure-activity studies of nonmacrocyclic rapamycin derivatives","volume":"3","author":"Holt","year":"1993","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.gene.2018.12.046_bb0230","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1021\/ja00075a008","article-title":"Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP12","volume":"115","author":"Holt","year":"1993","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.gene.2018.12.046_bb0235","first-page":"295","article-title":"Inhibitors of mammalian target of rapamycin as novel anti-tumor agents: from bench to clinic","volume":"3","author":"Huang","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.gene.2018.12.046_bb0240","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1054\/drup.2002.0227","article-title":"Mechanisms of resistance to rapamycins","volume":"4","author":"Huang","year":"2002","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.gene.2018.12.046_bb0245","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1471-4892(03)00071-7","article-title":"Targeting mTOR signaling for cancer therapy","volume":"3","author":"Huang","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.gene.2018.12.046_bb0250","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1432-1033.1995.tb20770.x","article-title":"Characterization and gene cloning of 1,3-beta-d-glucan synthase from Saccharomyces cerevisiae","volume":"231","author":"Inoue","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.gene.2018.12.046_bb0255","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.gene.2018.12.046_bb0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ctrv.2017.07.005","article-title":"Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: from laboratory to patients","volume":"59","author":"Janku","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.gene.2018.12.046_bb0265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0270","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/378641a0","article-title":"Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex","volume":"378","author":"Kissinger","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.gene.2018.12.046_bb0275","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1021\/ml900028r","article-title":"Discovery of GSK2126458, a highly potent inhibitor of PI3K and the mammalian target of rapamycin","volume":"1","author":"Knight","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.gene.2018.12.046_bb0280","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/MCB.11.3.1718","article-title":"Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein","volume":"11","author":"Koltin","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.gene.2018.12.046_bb0285","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/nar\/18.6.1643","article-title":"A second cyclophilin-related gene in Saccharomyces cerevisiae","volume":"18","author":"Koser","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2018.12.046_bb0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-1119(91)90489-X","article-title":"The CYP2 gene of Saccharomyces cerevisiae encodes a cyclosporin A-sensitive peptidyl-prolyl cis-trans isomerase with an N-terminal signal sequence","volume":"108","author":"Koser","year":"1991","journal-title":"Gene"},{"key":"10.1016\/j.gene.2018.12.046_bb0295","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-1119(93)90264-4","article-title":"The tyrosine-89 residue of yeast FKBP12 is required for rapamycin binding","volume":"129","author":"Koser","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.gene.2018.12.046_bb0300","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0092-8674(93)90144-F","article-title":"Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression","volume":"73","author":"Kunz","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0305","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/358070a0","article-title":"Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase","volume":"358","author":"Kuo","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.gene.2018.12.046_bb0310","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1016\/S1074-5521(99)80070-2","article-title":"The PIK-related kinases intercept conventional signaling pathways","volume":"6","author":"Kuruvilla","year":"1999","journal-title":"Chem. Biol."},{"key":"10.1016\/j.gene.2018.12.046_bb0315","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0320","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1534\/genetics.117.1124","article-title":"The stress-sensing TORC2 complex activates yeast AGC-family protein kinase Ypk1 at multiple novel sites","volume":"207","author":"Leskoske","year":"2017","journal-title":"Genetics"},{"key":"10.1016\/j.gene.2018.12.046_bb0325","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0330","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1021\/bi00131a002","article-title":"Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity","volume":"31","author":"Liu","year":"1992","journal-title":"Biochemist"},{"key":"10.1016\/j.gene.2018.12.046_bb0335","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1534\/genetics.111.133363","article-title":"Target of rapamycin (TOR) in nutrient signaling and growth control","volume":"189","author":"Loewith","year":"2011","journal-title":"Genetics"},{"key":"10.1016\/j.gene.2018.12.046_bb0340","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control","volume":"10","author":"Loewith","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0345","series-title":"TOR Target of Rapamycin","first-page":"1","article-title":"TOR: the first 10\u202fyears","author":"Lorberg","year":"2004"},{"key":"10.1016\/j.gene.2018.12.046_bb0350","doi-asserted-by":"crossref","first-page":"27531","DOI":"10.1074\/jbc.270.46.27531","article-title":"TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamcin","volume":"270","author":"Lorenz","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2018.12.046_bb0355","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0040-4039(00)77473-9","article-title":"Studies on the chemistry of rapamycin: novel transformations under Lewis-acid catalysis","volume":"34","author":"Luengo","year":"1993","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.gene.2018.12.046_bb0360","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1021\/jo00101a006","article-title":"Manipulation of the rapamycin effector domain. Selective nucleophilic substitution of the C7 methoxy group","volume":"59","author":"Luengo","year":"1994","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.gene.2018.12.046_bb0365","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1016\/S0040-4039(00)78248-7","article-title":"Studies on selective reductions of rapamycin","volume":"35","author":"Luengo","year":"1994","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.gene.2018.12.046_bb0370","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/1074-5521(95)90264-3","article-title":"Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface","volume":"2","author":"Luengo","year":"1995","journal-title":"Chem. Biol."},{"key":"10.1016\/j.gene.2018.12.046_bb0375","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMcibr1709384","article-title":"Game of TOR \u2013 the target of rapamycin rules four kingdoms","volume":"377","author":"Manning","year":"2017","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.gene.2018.12.046_bb0380","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1128\/MCB.15.10.5671","article-title":"Differential expression and function of two homologous subunits of yeast 1,3-beta-d-glucan synthase","volume":"15","author":"Mazur","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.gene.2018.12.046_bb0385","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0378-1119(92)90606-P","article-title":"The yeast cyclophilin multigene family: purification, cloning and characterization of a new isoform","volume":"111","author":"McLaughlin","year":"1992","journal-title":"Gene"},{"key":"10.1016\/j.gene.2018.12.046_bb0390","first-page":"470","article-title":"Singletons and multiples in scientific discovery","volume":"105","author":"Merton","year":"1961","journal-title":"Proc. Am. Philos. Soc."},{"key":"10.1016\/j.gene.2018.12.046_bb0395","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1017\/S0003975600000801","article-title":"Resistance to the systematic study of multiple discoveries in science","volume":"4","author":"Merton","year":"1963","journal-title":"Eur. J. Sociol."},{"key":"10.1016\/j.gene.2018.12.046_bb0400","series-title":"The Sociology of Science: Theoretical and Empirical Investigations","isbn-type":"print","first-page":"371","author":"Merton","year":"1973","ISBN":"https:\/\/id.crossref.org\/isbn\/9780226520926"},{"key":"10.1016\/j.gene.2018.12.046_bb0405","series-title":"Political Sci. Quarterly","first-page":"83","article-title":"Are inventions inevitable? A note on social evolution","volume":"vol. 37","author":"Ogburn","year":"1922"},{"key":"10.1016\/j.gene.2018.12.046_bb0410","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1099\/00221287-139-12-2973","article-title":"Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiae","volume":"139","author":"Parent","year":"1993","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.gene.2018.12.046_bb0415","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.humic.2017.05.004","article-title":"History of medicine: origin of the term microbiome and why it matters","volume":"4","author":"Prescott","year":"2017","journal-title":"Human Microbiome J."},{"key":"10.1016\/j.gene.2018.12.046_bb0420","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/2159-8290.CD-14-0332","article-title":"mTOR mutations in the crosshairs of targeted therapy","volume":"4","author":"Rejto","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.gene.2018.12.046_bb0425","doi-asserted-by":"crossref","first-page":"11818","DOI":"10.1073\/pnas.1716173114","article-title":"Twenty-five years of mTOR: uncovering the link from nutrients to growth","volume":"114","author":"Sabatini","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2018.12.046_bb0430","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","article-title":"RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs","volume":"78","author":"Sabatini","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0435","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1074\/jbc.270.2.815","article-title":"Isolation of a protein target of the FKBP12-rapamcyin complex in mammalian cells","volume":"270","author":"Sabers","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2018.12.046_bb0440","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.gene.2018.12.046_bb0445","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0450","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.93.24.13780","article-title":"TOR2 is required for organization of the actin cytoskeleton in yeast","volume":"93","author":"Schmidt","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2018.12.046_bb0455","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(00)81893-0","article-title":"The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2","volume":"88","author":"Schmidt","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0460","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1016\/S0041-1345(03)00211-2","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action","volume":"35","author":"Sehgal","year":"2003","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.gene.2018.12.046_bb0465","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7164\/antibiotics.28.727","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization","volume":"28","author":"Sehgal","year":"1975","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.gene.2018.12.046_bb0470","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrm3757","article-title":"Making new contacts: the mTOR network in metabolism and signalling crosstalk","volume":"15","author":"Shimobayashi","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.gene.2018.12.046_bb0475","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/341755a0","article-title":"A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin","volume":"341","author":"Siekierka","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.gene.2018.12.046_bb0480","doi-asserted-by":"crossref","first-page":"21011","DOI":"10.1016\/S0021-9258(17)45319-1","article-title":"The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase","volume":"265","author":"Siekierka","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2018.12.046_bb0485","doi-asserted-by":"crossref","first-page":"32027","DOI":"10.1016\/S0021-9258(18)31592-8","article-title":"Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue","volume":"269","author":"Stan","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2018.12.046_bb0490","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/346671a0","article-title":"Molecular cloning and the overexpression of the human FK506-binding protein FKBP","volume":"346","author":"Standaert","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.gene.2018.12.046_bb0495","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nphys3543","article-title":"Nobel prize 2015: Kajita and McDonald","volume":"11","author":"Taroni","year":"1995","journal-title":"Nat. Phys."},{"key":"10.1016\/j.gene.2018.12.046_bb0500","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.4049\/jimmunol.155.7.3418","article-title":"Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes","volume":"155","author":"Terada","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.gene.2018.12.046_bb0505","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/342953a0","article-title":"Sensitivity to cyclosporin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae","volume":"342","author":"Tropschug","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.gene.2018.12.046_bb0510","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1709302","article-title":"Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex","volume":"252","author":"Van Duyne","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.gene.2018.12.046_bb0515","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1021\/ja00019a057","article-title":"Atomic structure of the rapamycin human immunophilin FKBP-12 complex","volume":"113","author":"Van Duyne","year":"1991","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.gene.2018.12.046_bb0520","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/jmbi.1993.1012","article-title":"Atomic structure of the human immunophilin FKBP-12 complexes with FK506 and rapamycin","volume":"229","author":"Van Duyne","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.gene.2018.12.046_bb0525","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7164\/antibiotics.28.721","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle","volume":"28","author":"Vezina","year":"1975","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.gene.2018.12.046_bb0530","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-13-0353","article-title":"Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib","volume":"4","author":"Wagle","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.gene.2018.12.046_bb0535","doi-asserted-by":"crossref","first-page":"13115","DOI":"10.1016\/S0021-9258(18)42176-X","article-title":"Cyclosporin-A, the cyclophilin class of peptidyprolyl isomerases, and blockade of T-cell signal transduction","volume":"267","author":"Walsh","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2018.12.046_bb0540","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/jpet.111.185249","volume":"339","author":"Wang","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.gene.2018.12.046_bb0545","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1073\/pnas.88.3.1029","article-title":"FKB1 encodes a nonessential FK 506-binding protein in Saccharomyces cerevisiae and contains regions suggesting homology to the cyclophilins","volume":"88","author":"Wiederrecht","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2018.12.046_bb0550","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4615-1809-9_5","article-title":"Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells","volume":"1","author":"Wiederrecht","year":"1995","journal-title":"Prog. Cell Cycle Res."},{"key":"10.1016\/j.gene.2018.12.046_bb0555","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullshleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.gene.2018.12.046_bb0560","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1172\/JCI86120","article-title":"Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin","volume":"126","author":"Xu","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2018.12.046_bb0565","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.drudis.2011.02.008","article-title":"Targeting the mTOR kinase domain. The second generation of mTOR inhibitors","volume":"16","author":"Zhang","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.gene.2018.12.046_bb0570","first-page":"15","article-title":"mTOR inhibitors at a glance","volume":"7","author":"Zheng","year":"2015","journal-title":"Mol. Cell. Pharmacol."},{"key":"10.1016\/j.gene.2018.12.046_bb0575","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0092-8674(95)90058-6","article-title":"TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin","volume":"92","author":"Zheng","year":"1995","journal-title":"Cell"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918313088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918313088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T20:28:17Z","timestamp":1694550497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111918313088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":115,"alternative-id":["S0378111918313088"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2018.12.046","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Halcyon days of TOR: Reflections on the multiple independent discovery of the yeast and mammalian TOR proteins","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2018.12.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}